Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
World's biggest generic-drug empire created - ISRAEL21c
Teva Pharmaceutical Industries Limited (NYSE:TEVA) down to US$10b market cap, but institutional owners may not be as affected after a year of 7.9% returns - Simply Wall St News
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva Pharmaceutical basic share number 2011-2022 | Statista
US88163VAD10 - Teva Pharmaceutical Finance Co LLC Stock - Stock Price, Institutional Ownership, Shareholders
Teva Has Turned the Corner
TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Teva Pharmaceutical Industries Limited: Shareholders Board Members Managers and Company Profile | US8816242098 | MarketScreener
With 55% ownership of the shares, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is heavily dominated by institutional owners
Teva Pharmaceuticals - Wikipedia
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story | Seeking Alpha
Teva Has Turned the Corner
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
DEF 14A
